05197nam a22007695i 45000010014000000030009000140050017000230060019000400070015000590080041000740100015001150200018001300240031001480350021001790350022002000400033002220410008002550440015002630500028002780500016003060720023003220820019003451000087003642450110004512640057005612640011006183000031006293360026006603370026006863380036007123470024007484900051007725050442008235060104012655201438013695380049028075460016028565880112028726500069029846500061030536500070031146500081031846530010032656530011032756530011032866530011032976530015033086530022033236530018033456530016033636530028033796530029034077730114034367730100035507730104036507730105037547730096038598560084039558560049040398560068040889120061041569120065042179120079042829120024043619120021043859120021044069781503608757DE-B159720210526051534.0m|||||o||d||||||||cr || ||||||||210526t20202019cau    fo  d z      eng d  a2018033665  a97815036087577 a10.1515/97815036087572doi  a(DE-B1597)563719  a(OCoLC)1178769764  aDE-B1597bengcDE-B1597erda0 aeng  acaucUS-CA00aHD9999.B443bA7853 2019 4aHD9999.B443 7aBUS0701302bisacsh04a338.4/766060951 aIbata-Arens, Kathryn C., eauthor.4aut4http://id.loc.gov/vocabulary/relators/aut10aBeyond Technonationalism :bBiomedical Innovation and Entrepreneurship in Asia /cKathryn C. Ibata-Arens. 1aStanford, CA : bStanford University Press, c[2020] 4cÂ©2019  a1 online resource (352 p.)  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  atext filebPDF2rda0 aInnovation and Technology in the World Economy00tFrontmatter -- tCONTENTS -- tACKNOWLEDGMENTS -- tCHAPTER 1. NETWORKED TECHNONATIONALISM IN THE BIOMEDICAL INDUSTRY -- tCHAPTER 2. KNOWLEDGE AND NETWORK TYPOLOGY -- tCHAPTER 3. CLASSIC TECHNONATIONALISM IN JAPAN -- tCHAPTER 4. NEW NETWORKED TECHNONATIONALISM IN CHINA -- tCHAPTER 5. FROM CLOSED TO OPEN IN INDIA -- tCHAPTER 6. BORN GLOBAL IN SINGAPORE -- tCHAPTER 7. CONCLUSION -- tACRONYMS -- tNOTES -- tREFERENCES -- tINDEX0 arestricted accessuhttp://purl.org/coar/access_right/c_16ecfonline access with authorization2star  aThe biomedical industry, which includes biopharmaceuticals, genomics and stem cell therapies, and medical devices, is among the fastest growing worldwide. While it has been an economic development target of many national governments, Asia is currently on track to reach the epicenter of this growth. What accounts for the rapid and sustained economic growth of biomedicals in Asia? To answer this question, Kathryn Ibata-Arens integrates global and national data with original fieldwork to present a conceptual framework that considers how national governments have managed key factors, like innovative capacity, government policy, and firm-level strategies. Taking China, India, Japan, and Singapore in turn, she compares each country's underlying competitive advantages. What emerges is an argument that countries pursuing networked technonationalism (NTN) effectively upgrade their capacity for innovation and encourage entrepreneurial activity in targeted industries. In contrast to countries that engage in classic technonationalism-like Japan's developmental state approach-networked technonationalists are global minded to outside markets, while remaining nationalistic within the domestic economy. By bringing together aggregate data at the global and national level with original fieldwork and drawing on rich cases, Ibata-Arens telegraphs implications for innovation policy and entrepreneurship strategy in Asia-and beyond.  aMode of access: Internet via World Wide Web.  aIn English.0 aDescription based on online resource; title from PDF title page (publisher's Web site, viewed 26. Mai 2021) 0aBiotechnology industriesxGovernment policyzAsiavCase studies. 0aEntrepreneurshipxGovernment policyzAsiavCase studies. 0aTechnological innovationsxGovernment policyzAsiavCase studies. 7aBUSINESS & ECONOMICS / Industries / Pharmaceutical & Biotechnology.2bisacsh  aAsia.  aChina.  aIndia.  aJapan.  aSingapore.  adrug development.  aentrepreneur.  ainnovation.  ainternational business.  apharmaceutical industry.08iTitle is part of eBook package:dDe GruytertEBOOK PACKAGE Business and Economics 2020 Englishz978311070479208iTitle is part of eBook package:dDe GruytertEBOOK PACKAGE COMPLETE 2020 Englishz978311070471608iTitle is part of eBook package:dDe GruytertEBOOK PACKAGE COMPLETE 2020z9783110704518oZDB-23-DGG08iTitle is part of eBook package:dDe GruytertEBOOK PACKAGE Economics 2020z9783110704624oZDB-23-DBV08iTitle is part of eBook package:dDe GruytertSUP Complete eBook-Package 2019z978311069228040uhttps://doi.org/10.1515/9781503608757zCo-access DOI >> click Walter de Gruyter40uhttps://www.degruyter.com/isbn/9781503608757423Coveruhttps://www.degruyter.com/cover/covers/9781503608757.jpg  a978-3-11-069228-0  SUP Complete eBook-Package 2019b2019  a978-3-11-070471-6  EBOOK PACKAGE COMPLETE 2020 Englishb2020  a978-3-11-070479-2  EBOOK PACKAGE Business and Economics 2020 Englishb2020  aGBV-deGruyter-alles  aZDB-23-DBVb2020  aZDB-23-DGGb2020